Predictors of short- and long-term outcomes of patients undergoing transcatheter mitral valve edge-to-edge repair
Date issued
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
License
Abstract
OBJECTIVES
Transcatheter mitral valve repair (TMVR) by edge-to-edge therapy is an established treatment for severe mitral valve regurgitation (MR).
BACKGROUND
Symptomatic and prognostic benefit in functional MR has been shown recently; nevertheless, data on long-term outcomes are sparse.
METHODS AND RESULTS
We analyzed survival of patients treated with isolated edge-to-edge repair from June 2010 to March 2018 (primarily combined edge-to-edge repair with other mitral valve interventions was excluded) in a retrospective monocentric study. Overall, 627 consecutive patients (47.0% females, 78.6 years in mean) were included. Leading etiology was functional MR (57.4%). Follow-up regarding survival was available in 97.0%. While 97.6% were discharged alive, 75.7% were alive after a 1-year, 54.5% after 3-year, 37.6% after 5-year and 21.7% after 7-year follow-up. Higher logistic Euroscores and comorbidities such as COPD and renal insufficiency were associated with higher in-hospital and 1-year mortality. Importantly, in-hospital survival increased over the years.
CONCLUSIONS
With the present study we established high survival rates at discharge and after 1 year of patients treated with TMVR. This goes along with high implantation numbers, increased interventional experience and a better in-hospital survival over the years. Long-term mortality in turn was substantially influenced by comorbidities.
Description
Keywords
Citation
Published in
Catheterization and cardiovascular interventions, 97, 3, Wiley Interscience, New York, NY, 2021, https://doi.org/10.1002/ccd.29068